Sofinnova Partners
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio2 active
1Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Hemab Therapeutics
7Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| AAVantgarde Bio | Biotech | Active | — | — |
| GlycoEra | Biotech | Active | — | — |
| Hemab Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#136
Portfolio exits#160
Raises, 12 months#88
Co-investors#184
Co-investors
- 5AM VenturesVenture capital1 shared
- Access BiotechnologyVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
- Deep Track CapitalVenture capital1 shared
- Novo HoldingsVenture capital1 shared
- RA CapitalVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.